Back to Search
Start Over
Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
- Source :
-
Clinical nuclear medicine [Clin Nucl Med] 2018 Dec; Vol. 43 (12), pp. e439-e452. - Publication Year :
- 2018
-
Abstract
- There are recent advances, namely, a standardized method for reporting therapy response (Hopkins criteria), a multicenter prospective cohort study with excellent negative predictive value of F-FDG PET/CT for N0 clinical neck, a phase III multicenter randomized controlled study establishing the value of a negative posttherapy F-FDG PET/CT for patient management, a phase II randomized controlled study demonstrating radiation dose reduction strategies for human papilloma virus-related disease, and Food and Drug Administration approval of nivolumab for treatment of recurrent head and neck squamous cell carcinoma.
- Subjects :
- Evaluation Studies as Topic
Fluorodeoxyglucose F18
Head and Neck Neoplasms radiotherapy
Humans
Magnetic Resonance Imaging standards
Multimodal Imaging methods
Multimodal Imaging standards
Positron Emission Tomography Computed Tomography standards
Radiopharmaceuticals
Randomized Controlled Trials as Topic
Squamous Cell Carcinoma of Head and Neck radiotherapy
Head and Neck Neoplasms diagnostic imaging
Magnetic Resonance Imaging methods
Positron Emission Tomography Computed Tomography methods
Squamous Cell Carcinoma of Head and Neck diagnostic imaging
Subjects
Details
- Language :
- English
- ISSN :
- 1536-0229
- Volume :
- 43
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Clinical nuclear medicine
- Publication Type :
- Academic Journal
- Accession number :
- 30394934
- Full Text :
- https://doi.org/10.1097/RLU.0000000000002247